Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reissue Patent
2007-06-26
2007-06-26
Stockton, Laura L. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S377100
Reissue Patent
active
10757347
ABSTRACT:
Estrogen receptor-modulating pyrazole compounds are described in addition to methods and compositions for treating or preventing estrogen receptor-mediated disorders. The compounds described have been found to have unexpected and surprising activity in modulating estrogen receptor activity. Thus, the compounds of the present invention have utility in preventing or treating estrogen receptor-mediated disorders such as osteoporosis, breast and endometrial cancers, atherosclerosis, and Alzheimer's disease.
REFERENCES:
patent: 4112108 (1978-09-01), Nadelson
patent: 4229204 (1980-10-01), Howe
patent: 4325962 (1982-04-01), Rainer
patent: 2441504 (1974-08-01), None
patent: 31 19727 (1981-05-01), None
patent: 4126543 (1993-02-01), None
patent: 4230839 (1993-03-01), None
patent: 44 08 084 (1994-03-01), None
patent: 0 026 928 (1980-03-01), None
patent: 0442448 (1991-02-01), None
patent: 418845 (1991-03-01), None
patent: 0 623603 (1993-10-01), None
patent: 2104932 (1970-08-01), None
patent: WO 92/06962 (1992-04-01), None
patent: WO 95/15316 (1995-06-01), None
patent: WO 95/15318 (1995-06-01), None
patent: WO 96/15115 (1996-05-01), None
patent: WO 96/25405 (1996-08-01), None
patent: WO 97/01551 (1997-01-01), None
patent: WO 97/14679 (1997-04-01), None
patent: WO 00/75131 (2000-12-01), None
Meisenheimer et al., “Uber Triaryl-isoxazole”, Chemische Berichte, 1921, 3195:3206.
Krishna et al, “Synthesis and Physiological Activity of 3-Hydrxy-Pheny-5-Aryl Isoxazoles”, Chemical Abstracts, 1973, 79(13):487, 78661s.
Yamawaki et al, “Synthesis and biological Activity of the Metabolites of [3,4-Bis(4-Methoxyphenyl)-5-Isoxazolyl] Acetic Acid”, Chemical and Pharmaceutical Bulletin, 1988, 36(8):3142-3146.
Kim et al., “Reactions of 5-Substituted 3-Alkyl-and 3-Aryl-Isoxazoles with Tetrasulfar Tetranitride Antimony Pentachloride Complex . . . Thiadiazoles and their Mechanism of Formation”, Journal of the Chem. Soc. 1998, 14:2175-2180.
Mohan et al., “Search for Physiologically Active . . . Isoxazoles and their Physiological Activity”, Chemical Abstracts, 1968, 69(11):4107, 43834s.
Kasturi et al, “Reaction of Spironaphthalenones with Hydroxylamine Hydrochloride: Part IV”, Tetrahedron, 1995, 51(10):3051-3060.
Amme, Omar et al., “Synthesis, binding affinities and uterotrophic . . . pyrone derivatives”, XP-002136351, Eur J. Med Chem, 29:25-32,1995.
Duncan et al., “The Preparation of N-Carboalkoxypyrazoles . . . and Phenylhydrazones”, XP-00213650, J. Hetercyclic Chem., 24:555, 1987.
Fink et al., “Novel structural templates . . . synthesis of estrogens”, XP-000905542, Chemistry & Biology, 6:205-219 (Apr. 1999).
Wachter et al., “Tetrahydronaphthalenes: Influence of Heterocyclic . . . aroma and P450 17”, XP-002099563, J. Med. Chem. 39:834-841, 1996.
Sun et al., “Novel Ligands that function as Selective . . . Estrogen Receptor-β”, XP000908867, Endocrinology, vol. 140, 2:800-804, 1999.
Wrobel et al., “Conversion of 1-(O-Nitroaryl) Alkyl P-Tolysulfones into Isoxazoles”, Heterocycles, 1995, 40(1):187-190.
Omar et al., “Synthesis, Binding Affinities and Uterotrophic Activity of Some 2-Substituted Estradiol and Ring-A-Fused Pyrone Derivatives”Eur. J. Med. Chem. 29:25-32, 1994.
Bass and Srinivasan, “Synthesis of Poly(Arylene Ether-Pyrazoles) by Aromatic Nucleophilic Displacement Reactions”Polymer Preprints(AMS)32(1):619-620, year not available.
Bass and Srinivasan, “Synthesis of Novel Fluorine Containing Poly(Arylene Ether-Pyrazoles)”Polymer Preprints(AMS)34(1):441-442, 1993.
Eldin et al., “Hydazidoly Halides in Heterocyclic Synthesis: Systhesis of Several New Polyfunctional Pyrazole . . . ”Egyp. J. Pharm. Sci. 37(1-6):351-362, 1996.
Jerzmanowska et al., “Glikozyd 3-Acetylo-4-Hydrokskyflawonu I Jego Przemiany”Roczniki Chemii 42(12):2113-2119, 1968.
Youssef et al., “Synthesis and Mass Spectral Studies of Some 1-[2-Benzimidazolyl] or [6-Methyl-4 (1H)-Pyrimidinon-2-yl]-5-Substituted phenyl-3-Methylpyrazoles”Egypt. J. Pharm. Sci. 33(5-6):1099-1108, 1992.
Chen Liya
Desai Manoj C.
Huebner Verena D.
James Ian
Krywult Beata
Austin James E.
Chiron Corporation
Harbin Alisa A.
Stockton Laura L.
Suh Young J.
LandOfFree
Estrogen receptor modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Estrogen receptor modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Estrogen receptor modulators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3880002